Inhibition of neointima hyperplasia by the combined therapy of linagliptin and metformin via AMPK/Nox4 signaling in diabetic rats.

MLA

Zhang, Wen-Xu, et al. “Inhibition of Neointima Hyperplasia by the Combined Therapy of Linagliptin and Metformin via AMPK/Nox4 Signaling in Diabetic Rats.” Free Radical Biology & Medicine, vol. 143, Nov. 2019, pp. 153–63. EBSCOhost, https://doi.org/10.1016/j.freeradbiomed.2019.07.030.

APA

Zhang, W.-X., Tai, G.-J., Li, X.-X., & Xu, M. (2019). Inhibition of neointima hyperplasia by the combined therapy of linagliptin and metformin via AMPK/Nox4 signaling in diabetic rats. Free Radical Biology & Medicine, 143, 153–163. https://doi.org/10.1016/j.freeradbiomed.2019.07.030

Chicago

Zhang, Wen-Xu, Guang-Jie Tai, Xiao-Xue Li, and Ming Xu. 2019. “Inhibition of Neointima Hyperplasia by the Combined Therapy of Linagliptin and Metformin via AMPK/Nox4 Signaling in Diabetic Rats.” Free Radical Biology & Medicine 143 (November): 153–63. doi:10.1016/j.freeradbiomed.2019.07.030.